Guadeloupe Economic Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guadeloupe Economic Daily.

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

May 2026

Mo	Tu	We	Th	Fr	Sa	Su
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Press releases published on April 17, 2026

Apr. 17, 2026

Quantify Funds to Close STKd 100% NVDA & 100% AMD ETF (LAYS)

GlobeNewswire

Apr. 17, 2026

Sonoco To Report First Quarter 2026 Results

GlobeNewswire

Apr. 17, 2026

TTEC Schedules First Quarter 2026 Earnings Release and Webcast of Investor Conference Call

GlobeNewswire

Apr. 17, 2026

True North Social Expands Instagram Marketing Services to Help Brands Navigate Algorithm Changes and Content Evolution

GlobeNewswire

Apr. 17, 2026

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules

GlobeNewswire

Apr. 17, 2026

Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting

GlobeNewswire

Apr. 17, 2026

4DMT Announces New Employment Inducement Grants

GlobeNewswire

Apr. 17, 2026

CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Apr. 17, 2026

Vera Bradley Terminates Existing Shareholder Rights Plan

GlobeNewswire

Apr. 17, 2026

SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders

GlobeNewswire

Apr. 17, 2026

ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting

GlobeNewswire

Apr. 17, 2026

QuasarEdge Acquisition Corporation Announces Exercise of Over-Allotment Option

GlobeNewswire

Apr. 17, 2026

Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026

GlobeNewswire

Apr. 17, 2026

Talen Energy Announces Pricing of Senior Notes

GlobeNewswire

Apr. 17, 2026

VALUE LINE, INC. DIVIDEND HAS JUST BEEN RAISED FROM $1.30 TO $1.40 (ANNUALIZED) – ITS 12TH CONSECUTIVE INCREASE

GlobeNewswire

Apr. 17, 2026

Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

Apr. 17, 2026

Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2

GlobeNewswire

Apr. 17, 2026

Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting

GlobeNewswire

Apr. 17, 2026

Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting

GlobeNewswire

Apr. 17, 2026

Hingham Savings Reports First Quarter 2026 Results

GlobeNewswire